Platinum-Dye Complexes and Bleomycin Damage Repair
Author Information
Author(s): Y. Wang, T.S. Herman, B.A. Teicher
Primary Institution: Dana-Farber Cancer Institute
Hypothesis
Can new platinum-dye complexes inhibit the repair of potentially lethal damage caused by bleomycin in cancer cells?
Conclusion
Several new platinum complexes effectively inhibit DNA repair processes in cancer cells after bleomycin treatment.
Supporting Evidence
- New platinum complexes were more cytotoxic against exponentially growing cells than plateau phase cells.
- Pt(fast black)2 was the most effective inhibitor of bleomycin PLDR.
- Pt(thioflavin)2 and Pt(thionin)2 were also effective at inhibiting DNA repair.
Takeaway
Scientists created new platinum drugs to see if they could stop cancer cells from fixing damage caused by another drug called bleomycin.
Methodology
The study used a human squamous cell carcinoma cell line (SCC-25) to test the cytotoxicity of platinum-dye complexes and their ability to inhibit bleomycin-induced DNA repair.
Participant Demographics
The study used a human squamous cell carcinoma cell line derived from the tongue.
Want to read the original?
Access the complete publication on the publisher's website